Location: New York, NY
CIK: 0001974915 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $1.899B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACLX | Arcellx Inc | 2,750,000 | $181M | 9.5% | $64.66 | -3.7% | COMMON STOCK | 03940C100 |
| JAZZ | Jazz Pharmaceuticals PLC | 1,200,000 | $127M | 6.7% | $108.63 | 0.0% | SHS USD | G50871105 |
| CYTK | Cytokinetics Inc | 2,975,000 | $98.29M | 5.2% | $61.56 | -43.5% | COM NEW | 23282W605 |
| NUVL | Nuvalent Inc | 1,075,000 | $82.02M | 4.3% | $86.67 | -15.6% | COM | 670703107 |
| VERA | Vera Therapeutics Inc | 3,100,000 | $73.04M | 3.8% | $34.48 | -34.8% | CL A | 92337R101 |
| FOLD | Amicus Therapeutics Inc | 11,900,000 | $68.19M | 3.6% | $7.78 | -17.1% | COM | 03152W109 |
| XENE | Xenon Pharmaceuticals Inc | 2,000,000 | $62.6M | 3.3% | $37.23 | -12.4% | COM | 98420N105 |
| DNTH | Dianthus Therapeutics Inc | 3,200,000 | $59.62M | 3.1% | $21.02 | -10.7% | COM | 252828108 |
| SRRK | Scholar Rock Holding Corp | 1,500,000 | $53.13M | 2.8% | $37.53 | -16.4% | COM | 80706P103 |
| KALV | KalVista Pharmaceuticals Inc | 4,675,000 | $52.85M | 2.8% | $12.01 | +1.8% | COM | 483497103 |
| GEHC | GE HealthCare Technologies Inc | 700,000 | $51.85M | 2.7% | $74.29 | -6.4% | COMMON STOCK | 36266G107 |
| QURE | uniQure NV | 3,700,000 | $51.58M | 2.7% | $9.25 | +45.4% | SHS | N90064101 |
| BCAX | Bicara Therapeutics Inc | 5,000,000 | $46.45M | 2.4% | $14.14 | -15.7% | COM | 055477103 |
| ALC | Alcon AG | 525,000 | $46.35M | 2.4% | $89.55 | 0.0% | ORD SHS | H01301128 |
| RVMD | Revolution Medicines Inc | 1,200,000 | $44.15M | 2.3% | $38.42 | 0.0% | COM | 76155X100 |
| CRNX | Crinetics Pharmaceuticals Inc | 1,500,000 | $43.14M | 2.3% | $37.35 | -17.3% | COM | 22663K107 |
| EXAS | Exact Sciences Corp | 700,000 | $37.2M | 2.0% | $50.80 | 0.0% | COM | 30063P105 |
| CLDX | Celldex Therapeutics Inc | 1,750,000 | $35.61M | 1.9% | $20.34 | -4.3% | COM NEW | 15117B202 |
| ASND | Ascendis Pharma A/S | 200,000 | $34.52M | 1.8% | $143.28 | — | SPONSORED ADR | 04351P101 |
| IMTX | Immatics NV | 6,250,000 | $33.63M | 1.8% | $9.29 | -46.6% | SHS | N44445109 |
| GERN | Geron Corp | 23,775,000 | $33.52M | 1.8% | $3.11 | -54.3% | COM | 374163103 |
| GMED | Globus Medical Inc | 500,000 | $29.51M | 1.6% | $70.31 | -8.1% | CL A | 379577208 |
| BMRN | BioMarin Pharmaceutical Inc | 500,000 | $27.48M | 1.4% | $58.89 | 0.0% | COM | 09061G101 |
| MLTX | MoonLake Immunotherapeutics | 550,000 | $25.96M | 1.4% | $41.59 | -2.1% | CLASS A ORD | 61559X104 |
| TYRA | Tyra Biosciences Inc | 2,655,000 | $25.41M | 1.3% | $14.73 | -35.5% | COM | 90240B106 |
| SVRA | Savara Inc | 11,015,000 | $25.11M | 1.3% | $4.17 | -34.9% | COM | 805111101 |
| COO | Cooper Cos Inc/The | 350,000 | $24.91M | 1.3% | $76.56 | 0.0% | COM | 216648501 |
| GPCR | Structure Therapeutics Inc | 1,200,000 | $24.89M | 1.3% | $36.10 | — | SPONSORED ADS | 86366E106 |
| — | Cidara Therapeutics Inc | 500,000 | $24.36M | 1.3% | $21.54 | — | COM NEW | 171757206 |
| — | Astria Therapeutics Inc | 4,522,000 | $24.24M | 1.3% | $10.34 | — | COM | 04635X102 |
| ABT | Abbott Laboratories | 175,000 | $23.8M | 1.3% | $130.60 | 0.0% | COM | 002824100 |
| EW | Edwards Lifesciences Corp | 300,000 | $23.46M | 1.2% | $74.58 | 0.0% | COM | 28176E108 |
| NRIX | Nurix Therapeutics Inc | 2,000,000 | $22.78M | 1.2% | $14.08 | -23.2% | COM | 67080M103 |
| COGT | Cogent Biosciences Inc | 3,080,000 | $22.11M | 1.2% | $7.78 | -28.7% | COM | 19240Q201 |
| BRKR | Bruker Corp | 500,000 | $20.6M | 1.1% | $46.46 | -17.2% | COM | 116794108 |
| IONS | Ionis Pharmaceuticals Inc | 500,000 | $19.75M | 1.0% | $32.73 | 0.0% | COM | 462222100 |
| DAWN | Day One Biopharmaceuticals Inc | 3,000,000 | $19.5M | 1.0% | $12.02 | -42.7% | COM | 23954D109 |
| MDT | Medtronic PLC | 195,000 | $17M | 0.9% | $83.50 | 0.0% | SHS | G5960L103 |
| PRGO | Perrigo Co PLC | 625,000 | $16.7M | 0.9% | $26.15 | +0.2% | SHS | G97822103 |
| ZYME | Zymeworks Inc | 1,150,000 | $14.43M | 0.8% | $11.99 | -0.7% | COM | 98985Y108 |
| BDTX | Black Diamond Therapeutics Inc | 5,600,000 | $13.89M | 0.7% | $5.15 | -62.6% | COM | 09203E105 |
| LXEO | Lexeo Therapeutics Inc | 3,228,161 | $12.98M | 0.7% | $6.61 | -50.3% | COM | 52886X107 |
| NYXH | Nyxoah SA | 1,402,002 | $10.49M | 0.6% | $8.73 | -21.3% | SHS | B6S7WD106 |
| TMO | Thermo Fisher Scientific Inc | 25,000 | $10.14M | 0.5% | $417.06 | 0.0% | COM | 883556102 |
| DHR | Danaher Corp | 50,000 | $9.877M | 0.5% | $216.97 | -11.0% | COM | 235851102 |
| BBNX | Beta Bionics Inc | 550,000 | $8.008M | 0.4% | $14.16 | 0.0% | COM | 08659B102 |
| IRON | Disc Medicine Inc | 140,000 | $7.414M | 0.4% | $46.97 | 0.0% | COM | 254604101 |
| SLDB | Solid Biosciences Inc | 1,505,000 | $7.329M | 0.4% | $8.93 | -60.4% | COM NEW | 83422E204 |
| TSHA | Taysha Gene Therapies Inc | 3,000,000 | $6.93M | 0.4% | $2.17 | 0.0% | COM SHS | 877619106 |
| DYN | Dyne Therapeutics Inc | 727,500 | $6.926M | 0.4% | $14.30 | -23.0% | COM | 26818M108 |
| TVTX | Travere Therapeutics Inc | 355,000 | $5.254M | 0.3% | $16.57 | 0.0% | COM | 89422G107 |
| ELVN | Enliven Therapeutics Inc | 250,000 | $5.015M | 0.3% | $18.93 | 0.0% | COM | 29337E102 |
| VYGR | Voyager Therapeutics Inc | 1,475,000 | $4.587M | 0.2% | $6.46 | — | COM | 92915B106 |
| ZBH | Zimmer Biomet Holdings Inc | 50,000 | $4.561M | 0.2% | $95.97 | 0.0% | COM | 98956P102 |
| BDX | Becton Dickinson & Co | 25,000 | $4.306M | 0.2% | $180.47 | 0.0% | COM | 075887109 |
| VTYX | Ventyx Biosciences Inc | 2,000,000 | $4.28M | 0.2% | $3.51 | -54.0% | COM | 92332V107 |
| LNTH | Lantheus Holdings Inc | 50,000 | $4.093M | 0.2% | $87.82 | 0.0% | COM | 516544103 |
| NBIX | Neurocrine Biosciences Inc | 30,000 | $3.771M | 0.2% | $114.68 | 0.0% | COM | 64125C109 |
| — | Applied Therapeutics Inc | 11,500,000 | $3.578M | 0.2% | $1.17 | — | COM | 03828A101 |
| FATE | Fate Therapeutics Inc | 2,515,000 | $2.817M | 0.1% | $3.20 | -63.7% | COM | 31189P102 |
| — | Passage Bio Inc | 6,100,000 | $2.442M | 0.1% | $1.21 | — | COM | 702712100 |
| ANRO | Alto Neuroscience Inc | 950,000 | $2.09M | 0.1% | $11.40 | -79.1% | COM SHS | 02157Q109 |
| — | Sutro Biopharma Inc | 2,600,000 | $1.856M | 0.1% | $1.83 | — | COM | 869367102 |
| OKUR | OnKure Therapeutics Inc | 635,000 | $1.518M | 0.1% | $15.14 | -82.7% | COM CL A | 68277Q105 |
| VRDN | Viridian Therapeutics Inc | 100,000 | $1.398M | 0.1% | $13.57 | 0.0% | COM | 92790C104 |
| ALEC | Alector Inc | 976,992 | $1.368M | 0.1% | $1.45 | -13.4% | COM | 014442107 |
| ENGN | Engene Holdings Inc | 370,000 | $1.347M | 0.1% | $7.77 | -51.7% | COM | 29286M105 |
| ARQT | Arcutis Biotherapeutics Inc | 95,000 | $1.332M | 0.1% | $14.02 | 0.0% | COM | 03969K108 |
| ATRA | Atara Biotherapeutics Inc | 94,085 | $726K | 0.0% | $14.38 | -49.2% | COM NEW | 046513206 |
| MGNX | MacroGenics Inc | 280,000 | $339K | 0.0% | $14.22 | -89.8% | COM | 556099109 |
| TENX | Tenax Therapeutics Inc | 53,439 | $308K | 0.0% | $3.62 | +59.6% | COM NEW | 88032L605 |
| TRAW | Traws Pharma Inc | 149,800 | $222K | 0.0% | $5.36 | -70.3% | COM NEW | 68232V884 |